Clear cell carcinoma of the cervix: A multi-institutional review in the post-DES era

Gynecologic Oncology

Volumn 109, Issue 3, 2008, Pages 335-339

  Thomas, M Bijoy ^a   Wright, Jason D ^b   Leiser, Aliza L ^c   Chi, Dennis S ^c   Mutch, David G ^b   Podratz, Karl C ^a   Dowdy, Sean C ^a  

^a MAYO CLINIC   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cervical clear cell carcinoma; Radiation therapy; Radical hysterectomy; Systematic lymphadenectomy

Indexed keywords

DIETHYLSTILBESTROL;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CERVICAL CLEAR CELL CARCINOMA; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; HUMAN; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PELVIS LYMPH NODE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING;

ADENOCARCINOMA, CLEAR CELL; ADULT; CHEMOTHERAPY, ADJUVANT; DIETHYLSTILBESTROL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 44549088644     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.02.007     Document Type: Article

References (21)

1. Herbst A.L., Ulfelder H., and Poskanzer D.C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 15 284(15) (1971) 878-881
2. Bulletin F.D. Diethylstilbestrol contraindicated in pregnancy (1971), US Department of Health, Education, and Welfare, Washington DC
3. Herbst A.L., Norusis M.J., Rosenow P.J., Welch W.R., and Scully R.E. An analysis of 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival. Gynecol Oncol 7 2 (1979) 111-122
4. Herbst A.L. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES). Gynecol Oncol 76 2 (2000) 147-156
5. Reich O., Tamussino K., Lahousen M., Pickel H., Haas J., and Winter R. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol. Gynecol Oncol 76 3 (2000) 331-335
6. Waggoner S.E., Mittendorf R., Biney N., Anderson D., and Herbst A.L. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Gynecol Oncol 55 2 (1994) 238-244
7. Peters III W.A., Liu P.Y., Barrett II R.J., Stock R.J., Monk B.J., Berek J.S., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 8 (2000) 1606-1613
8. Benedet J.L., Odicino F., Maisonneuve P., Beller U., Creasman W.T., Heintz A.P., et al. Carcinoma of the cervix uteri. J Epidemiol Biostat 6 1 (2001) 7-43
9. Piver M.S., Rutledge F., and Smith J.P. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44 (1974) 265
10. Hanselaar A., van Loosbroek M., Schuurbiers O., Helmerhorst T., Bulten J., and Bernheim J. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks. Cancer 79 11 (1997) 2229-2236
11. Hanselaar A.G., Van Leusen N.D., De Wilde P.C., and Vooijs G.P. Clear cell adenocarcinoma of the vagina and cervix. A report of the Central Netherlands Registry with emphasis on early detection and prognosis. Cancer 67 7 (1991) 1971-1978
12. Brinton L.A., Herrero R., Reeves W.C., de Britton R.C., Gaitan E., and Tenorio F. Risk factors for cervical cancer by histology. Gynecol Oncol 51 3 (1993) 301-306
13. Pirog E.C., Kleter B., Olgac S., Bobkiewicz P., Lindeman J., Quint W.G., et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 157 4 (2000) 1055-1062
14. Goto K., Takeuchi Y., Yakihara A., and Kotsuji F. Synchronous invasive squamous cell carcinoma and clear cell adenocarcinoma of the uterine cervix: a different human papillomavirus status. Gynecol Oncol 97 3 (2005) 976-979
15. Havrilesky L.J., Leath C.A., Huh W., Calingaert B., Bentley R.C., Soper J.T., et al. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. Gynecol Oncol 93 2 (2004) 429-434
16. Benedetti-Panici P., Maneschi F., Scambia G., Greggi S., Cutillo G., D'Andrea G., et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 62 1 (1996) 19-24
17. Pikaart D.P., Holloway R.W., Ahmad S., Finkler N.J., Bigsby IV G.E., Ortiz B.H., et al. Clinical-pathologic and morbidity analyses of types 2 and 3 abdominal radical hysterectomy for cervical cancer. Gynecol Oncol 107 2 (2007) 205-210
18. Sakuragi N. Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int J Clin Oncol 12 3 (2007) 165-175
19. Sedlis A., Bundy B.N., Rotman M.Z., Lentz S.S., Muderspach L.I., and Zaino R.J. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol 73 2 (1999) 177-183
20. Jones W.B., Tan L.K., and Lewis J.L. Late recurrence of clear cell adenocarcinoma of the vagina and cervix: a report of three cases. Gynecol Oncol 51 2 (1993) 266-271
21. Lea J.S., Sheets E.E., Wenham R.M., Duska L.R., Coleman R.L., Miller D.S., et al. Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival. Gynecol Oncol 84 1 (2002) 115-119